Arrow Financial Corp

Kenvue shares declined, trading below the value of Kimberly-Clark's cash-and-stock acquisition offer after a slide in the acquirer's stock. The gap reflects persistent investor worries about deal hurdles.

MercadoLibre shares slipped following a Q4 profit shortfall, as increased investment in logistics and credit expansion pressured margins despite strong revenue growth.

Arrowhead Pharmaceuticals shares experienced heightened trading activity and a slight decline following its transition to the S&P MidCap 400 index. Goldman Sachs reiterated a Neutral stance, highlighting pivotal 2026 clinical data and competitive pressures.